logo
Young Edge: Why vaping or e-cigarettes continue to lure Pune young adults despite risks

Young Edge: Why vaping or e-cigarettes continue to lure Pune young adults despite risks

Written by Siddhi Pati,
Despite being banned, vapes are popular among young adults in Pune as many are under the assumption that e-cigarettes are less harmful than traditional cigarettes, while others are simply drawn to the trend under peer influence.
Vaping or electronic cigarettes are banned under the Prohibition of Electronic Cigarettes Act (2019).
A Kharadi resident, who did not want to be named, said he has several friends addicted to vaping. He added that most people don't think it is harming their health until they start feeling symptoms like throat irritation or a heaviness in their voice.
'Vapes are easy to access, even though they're illegal, since many big smoke shops continue to sell them. I have seen these shops import vapes and e-cigarettes from African, South Asian, and especially Gulf countries,' he said.
A student from Viman Nagar shared that there is a perception that smoking is old and unhealthy. 'Even if vaping isn't completely healthy, it feels like a better option, since it also causes less discomfort.'
Many users have said that youngsters try out vaping to seek new experiences and later on at least become active tobacco smokers.
A student from Kothrud admitted, 'I go to house parties, and even if I don't want to use the vape, it just gets passed around. And I end up smoking it.'
A vaping addict pointed out the emotional pressure involved in the process. 'I got into it under peer pressure, and now it has gotten very difficult to quit. And unlike cigarettes, vapes have a variety. So, it's not the feeling of smoking and the nicotine hit. It's also the fact that there is so much more to try. I can carry them everywhere I go. I just need to charge, and it's ready,' she said.
Another student from Lohegaon highlighted how easy it is to get hooked, 'I think it's the kick of nicotine that makes vapes so addictive. They are very easily available in every other smoke shop for Rs 2,000–Rs 3,000.'
According to psychologists, vapes and e-cigarettes contain addictive chemicals that make quitting hard.
'Many young adults use vaping as a coping mechanism to deal with difficult emotions. Over time, it becomes a habit. They vape when bored, sad, or anxious. Vapes and e-cigarettes are also marketed as sleek and sophisticated, adding to the factor of increased peer-pressure among young adults, and driving them to use these devices,' explained Shreyash Chhajed, clinical psychologist.
Health professionals have warned against the common misconception that vaping is a safe alternative. 'They deliver nicotine, which raises heart rate and blood pressure. E-cigarettes also release substances like formaldehyde and TSNAs, which can increase cancer risk. For the lungs, vaping can cause inflammation, oxidative stress, and even conditions like EVALI and 'popcorn lung,' said Dr Vivek Gaikwad, Pune-based cardiologist.
The fact that the combination of easy access, peer influence, emotional dependence, and lack of awareness continues to fuel this growing trend is a matter of concern among health experts. Vaping may feel safer than smoking, but the risks are real and rising, they said.
(Siddhi Patil is an intern with The Indian Express)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bharat Biotech in-licences GSK's Shigella vaccine candidate
Bharat Biotech in-licences GSK's Shigella vaccine candidate

Time of India

time34 minutes ago

  • Time of India

Bharat Biotech in-licences GSK's Shigella vaccine candidate

HYDERABAD: Vaccine maker Bharat Biotech International Limited (BBIL) has in-licenced pharma giant GSK's Shigella vaccine candidate -- altSonflex1-2-3. The vaccine candidate was being developed by GSK against Shigellosis, which is a severe form of bacterial diarrhoea that largely affects children aged five years and below in low- and middle-income countries. While GSK has already conducted Phase-I and II trials in Europe and Africa, Bharat Biotech will be taking up further development with Phase-III clinical trials, regulatory advancement and large-scale manufacturing, Bharat Biotech said on Thursday. As part of the agreement, GSK will continue its support to the programme by assisting with clinical trial design, securing external funding, and contributing to the access and delivery plans and commercialisation strategy. The vaccine has been developed on the innovative generalized modules for membrane antigens (GMMA) based platform, which uses bacterial outer membranes to deliver the O Antigen to the immune system. 'The in-licensed candidate, altSonflex1-2-3, has already shown encouraging results in early-stage clinical trials. A Phase 1 study conducted in Europe demonstrated a favourable safety profile and strong immune response,' the Hyderabad-based vaccine maker said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Is it better to shower in the morning or at night? Here's what a microbiologist says CNA Read More Undo 'Subsequent Phase 2 trials in Africa, including vaccination of 9-month-old infants—the primary target population—reported no safety concerns. Interim results from 2024 confirmed that the candidate met its pre-set immunogenicity goals,' it added. Bharat Biotech executive chairman Dr Krishna Ella said: 'With no approved vaccine currently available for Shigella and antimicrobial resistance on the rise, there is an urgent need for scalable, science-backed solutions focused on low and middle-income countries. This collaboration combines our strengths in innovation, manufacturing, and global health commitment.' He pointed out that the addition of this vaccine candidate to its portfolio will strengthen Bharat Biotech's already significant presence in vaccines for diarrhoeal infections, including rotavirus, typhoid, polio, non-typhoidal salmonella, cholera, and paratyphi. GSK already has an established relationship with BBIL, after it signed a product transfer agreement for the world's first malaria vaccine, RTS,S, to the Hyderabad-based company in 2021. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

Neurotech and brain data: New frontier of privacy concerns
Neurotech and brain data: New frontier of privacy concerns

Hindustan Times

time43 minutes ago

  • Hindustan Times

Neurotech and brain data: New frontier of privacy concerns

Consumer neurotechnology is no longer confined to sci-fi or academic labs. Thanks to AI advancements and shrinking chip sizes, devices that read brain activity, like EEG headsets, mood-tracking earbuds, and brain-controlled gaming accessories are entering the mainstream. Since 2011, over 130 startups have jumped into the consumer neurotech space. These tools, often embedded in wearables, promise productivity boosts, mental health insights, and immersive control over AR/VR environments. Tech giants like Apple and Snap are already exploring brain-computer interfaces (BCIs) for future headsets that could respond to mental states in real time. How Neurotech Works—And why It's risky EEG-based devices dominate this landscape, powering nearly 65% of consumer neurotech products. They track brainwave patterns linked to emotions, focus, and engagement levels. That may sound harmless until you realise this data could be mined to predict behaviours, preferences, or even political leanings. Imagine hyper-targeted ads based not on clicks, but on neural spikes. Or worse, cognitive surveillance, where employers or governments monitor attention levels, emotional stress, or signs of dissent. Cyberattacks targeting BCIs could introduce 'mental hacks', altering thought patterns or inducing confusion and distress. As one expert puts it, 'Brain data reveals thoughts before they're consciously expressed.' Regulatory gaps and urgent challenges The legal protections around all this? Alarmingly thin. While medical neurotech is regulated (MRIs or brain implants), consumer-grade EEG headsets fall into a grey zone. In the U.S., the FDA only monitors medical devices. State laws in places like California and Colorado require user consent for neural data use, but there's little enforcement. Internationally, concerns are mounting: China has tested neurotech in workplaces to track employee fatigue, while neuromarketing firms tap EEG feedback to fine-tune advertisements. 'Neural data could be weaponized for psychological warfare or blackmail.' Path forward So what now? We need clear federal laws that define how brain data can be collected, stored, and shared. Users should know exactly what's being tracked and who has access to it. Neural data must be encrypted, just like financial or medical records. Most importantly, the public must be made aware of what 'brain transparency' really means. Because the future of privacy may no longer be in your hands, but in your head. First Published Date: 12 Jun, 21:23 IST

Social media fuelling 'devastating' kids' mental health crisis: NGO
Social media fuelling 'devastating' kids' mental health crisis: NGO

Time of India

timean hour ago

  • Time of India

Social media fuelling 'devastating' kids' mental health crisis: NGO

HighlightsThe KidsRights report reveals that one in seven children and adolescents aged 10 to 19 suffer from mental health issues, with a global suicide rate of six per 100,000 among those aged 15 to 19. Marc Dullaert, chairman of KidsRights, emphasizes that the unchecked expansion of social media platforms is exacerbating the mental health crisis among children, calling for immediate coordinated action worldwide. The report warns against blanket bans on social media for under-16s, stating that such measures may infringe on children's civil and political rights, while advocating for comprehensive child rights impact assessments and better education. The "unchecked expansion" of social media platforms is driving an unprecedented global mental health crisis in kids and teens, a children's NGO said Wednesday, calling for urgent coordinated action worldwide. The KidsRights report said one in seven children and adolescents aged between 10 and 19 suffered mental health issues, with the global suicide rate at six per 100,000 for those aged 15-19. Even these high rates represent "the tip of the iceberg" as suicide is widely under-reported due to stigma, according to the Amsterdam-based group. "This year's report is a wake-up call that we cannot ignore any longer" said Marc Dullaert, KidsRights chairman. "The mental health... crisis among our children has reached a tipping point, exacerbated by the unchecked expansion of social media platforms that prioritise engagement over child safety," he added. The report said what it termed "problematic" social media use was on the rise, with a direct link between heavy internet use and suicide attempts. However, blanket bans are not the answer, the group warned. Australia passed a law to ban social media use for under-16s. "Such blanket bans may infringe on children's civil and political rights," including access to information, said the report. The group urged "comprehensive child rights impact assessments " at a global level for social media platforms, better education for kids, and improved training for mental health professionals. The report seized on the popularity of Netflix sensation "Adolescence", which highlighted some of the toxic content kids view online. The mini-series "demonstrated global awareness of these issues, but awareness alone is insufficient," said Dullaert. "We need concrete action to ensure that the digital revolution serves to enhance, not endanger, the wellbeing of the world's 2.2 billion children," he said. "The time for half-measures is over.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store